EnsoData applies AI to waveform data from sleep studies, automating the scoring and analysis that sleep clinics, hospitals, and home sleep testing providers previously did by hand. The company says its software is the first AI technology cleared by the FDA to aid clinicians in diagnosing sleep disorders and sleep apnea. EnsoData was founded in 2015 by Chris Fernandez, Sam Rusk, and Nick Glattard, who met at the University of Wisconsin-Madison, and is headquartered in Madison.
Builder’s Brief
EnsoData is a healthcare tool on Falcoscan. FDA-cleared AI that automates sleep study scoring for clinicians. Falcoscan rates EnsoData with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. EnsoData is founded in 2015, currently at Series_b stage. Pricing: Paid.
Market position · Healthcare
How EnsoData compares in Healthcare
EnsoData's opportunity score of 84 ranks #51 of 192 live Healthcare tools on Falcoscan, 1.4 points above the category average of 82.6. Its saturation score is 11/100, against a category average of 11. 86 of the 192 live Healthcare tools carry a hot signal, and Falcoscan has recorded 8 shutdowns in the category.
The top-rated live Healthcare tools on Falcoscan, other than EnsoData, are DeepMind AlphaFold, Nuance DAX Copilot, Viz.ai AI Stroke Response, Tempus AI Diagnostics, and Viz.ai Stroke AI.
Is EnsoData still operating?
Yes. Falcoscan's operating checks list EnsoData as active.
Where is EnsoData based?
EnsoData is headquartered in Madison, United States.
Does EnsoData have an API?
Falcoscan's records show no public API for EnsoData.
Who is EnsoData for?
EnsoData is built for sleep clinics, hospitals, and academic medical centers.